LUCD•benzinga•
Cantor Fitzgerald Maintains Overweight on Lucid Diagnostics, Lowers Price Target to $2
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 15, 2024 by benzinga